Objectives: N-methyladenosine (mA) RNA methylation is implicated in the progression of multiple cancers via influencing mRNA modification. YTHDF1 can act as an oncogene in gastric cancer (GC), while the biological mechanisms via which YTHDF1 regulates gastric tumorigenesis through mA modification remain largely unknown.

Methods: GEO and TCGA cohorts were analyzed for differentially expressed mA modification components in GC clinical specimens and their association with clinical prognosis. Transwell and flow cytometry assays as well as subcutaneous xenograft and lung metastasis models were used to evaluate the phenotype of YTHDF1 in GC. Intersection of RNA/MeRIP-seq, luciferase assay, RIP-PCR, RNA pull-down and MeRIP-PCR was used to identify YTHDF1- modified USP14 and its mA levels in GC cells.

Results: High-expressed YTHDF1 was found in GC tissues and was related to poor prognosis, acting as an independent prognostic factor of poor survival in GC patients. YTHDF1 deficiency inhibited cell proliferation and invasion (), and gastric tumorigenesis and lung metastasis () and also induced cell apoptosis. Intersection assays revealed that YTHDF1 promoted USP14 protein translation in an mA-dependent manner. USP14 upregulation was positively correlated with YTHDF1 expression and indicated a poor prognosis in GC.

Conclusion: Our data suggested that mA reader YTHDF1 facilitated tumorigenesis and metastasis of GC by promoting USP14 protein translation in an mA-dependent manner and might provide a potential target for GC treatment.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006284PMC
http://dx.doi.org/10.3389/fcell.2021.647702DOI Listing

Publication Analysis

Top Keywords

translation ma-dependent
12
ma-dependent manner
12
reader ythdf1
8
tumorigenesis metastasis
8
gastric cancer
8
ythdf1
8
gastric tumorigenesis
8
lung metastasis
8
poor prognosis
8
usp14 protein
8

Similar Publications

Nrf2 expression, mitochondrial fission, and neuronal apoptosis in the prefrontal cortex of methamphetamine abusers and rats.

Brain Res

August 2024

School of Forensic Medicine, National Health Commission Key (NHC) Laboratory of Drug Addiction Medicine, Kunming Medical University, Kunming 650500, China. Electronic address:

Article Synopsis
  • Methamphetamine (MA) is a widely abused stimulant that causes neurotoxicity through oxidative stress and apoptosis, particularly affecting dopaminergic neurons.
  • The study investigated how MA influences various proteins related to neuroprotection (Nrf2), mitochondrial dynamics (Mfn1, Drp1), and apoptosis (Caspase 3) in brain tissue of MA users and a rat model.
  • Results showed that levels of Nrf2 and Mfn1 decreased while levels of Drp1, Cyt-c, and Caspase 3 increased in MA users, suggesting that Nrf2 may be crucial in mediating the harmful effects of MA on neurons through oxidative stress and mitochondrial dysfunction.
View Article and Find Full Text PDF

Background: a significant percentage of methamphetamine (MA) dependent patients develop psychosis. The associations between oxidative pathways and MA-induced psychosis (MIP) are not well delineated.

Objective: the aim of this study is to delineate whether acute MA intoxication in MA dependent patients is accompanied by increased nitro-oxidative stress and whether the latter is associated with MIP.

View Article and Find Full Text PDF

Methamphetamine (MA) dependence is associated with executive dysfunction, but no studies have evaluated MA-related elevations in neurocognitive intraindividual variability (IIV), an expression of cognitive dyscontrol linked to poor daily functioning in populations with frontal systems injury. We examined IIV during a vigilance task in a well-characterized sample of 35 MA-dependent (MA+) and 55 non-MA using comparison participants (MA-) as part of a larger neuropsychological battery that included self-report and performance-based measures of everyday functioning. A mixed model ANOVA was conducted while controlling for covariates, including factors that differed between the groups (e.

View Article and Find Full Text PDF

Dopamine D3 receptors as a therapeutic target for methamphetamine dependence.

Am J Drug Alcohol Abuse

January 2014

Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA , USA .

Background: Methamphetamine (MA) use disorders are major public health problems nationally and worldwide and treatment remains an unmet need.

Objectives: (1) To review preclinical and clinical studies identifying the dopamine D3 receptor as a therapeutic target for substance use disorders (SUDs), including MA dependence, (2) to consider buspirone (Buspar®) as a potential medication based on its dopamine D3 receptor antagonist properties, and (3) to evaluate the safety and initial efficacy of buspirone in a pilot study of MA-dependent individuals.

Methods: Literature on the dopamine D3 receptor as a therapeutic target and on the potential of buspirone as a novel therapy for MA dependence was reviewed.

View Article and Find Full Text PDF

Human immunodeficiency virus (HIV) infection and methamphetamine (MA) dependence are associated with neural injury preferentially involving frontostriatal circuits. Little is known, however, about how these commonly comorbid conditions impact behavioral presentations typically associated with frontal systems dysfunction. Our sample comprised 47 HIV-uninfected/MA-nondependent; 25 HIV-uninfected/MA-dependent; 36 HIV-infected/MA-nondependent; and 28 HIV-infected/MA-dependent subjects.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!